Aseptic loosening of BonelocR cemented hip prostheses.
We present a systematic clinical and radiographic study of 147 patients who had total hip replacements from February 1992 to May 1993. BonelocR cement was used in 108, and PalacosR cement with gentamicin in 39 patients who had an increased risk of infection. At follow-up after 24 to 39 months, 26 cases with BonelocR cement had failed; there were no clinical failures in the PalacosR group.
Wedderkopp
N
N
Orthopaedic Department, Svendborg Hospital, Sweden.
Andersen-Ranberg
F
F
Andersen
M B
MB
Termansen
N B
NB
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000627:therapeutic use*; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use*; D008875:Middle Aged; D011475:Prosthesis Failure; D012307:Risk Factors; D016019:Survival Analysis; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D008689:Methacrylates; C073735:methylmethacrylate-n-decylmethacrylate-isobornylmethacrylate